Candidemia Following Ureteric Stent Placement in a Patient With Type 2 Diabetes Treated With Canagliflozin

Candidemia Following Ureteric Stent Placement in a Patient With Type 2 Diabetes Treated With Canagliflozin

A 38-year-old female patient with well-controlled type 2 diabetes mellitus treated with canagliflozin underwent ureteral stent placement for obstructive renal calculi. Ten days following ureteroscopy and ureteral stenting, she developed fevers and blood cultures grew Candida glabrata (C. glabrata)....

Full description

Bibliographic Details
Main Authors: Rishi Raj, Jon Hendrie, Aasems Jacob, Derick Adams
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Endocrinology
Subjects:
candidemia
candiduria
sodium-glucose co-transporter 2 inhibitors
canagliflozin
diabetes mellitus
ureteral stent
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2019.00020/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2019.00020/full

Similar Items